Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
World J Surg. 2021 Apr;45(4):1152-1158. doi: 10.1007/s00268-020-05914-3. Epub 2021 Jan 25.
The aim of this study was to analyze changes in characteristics of HCC and the modes of LR over 20 years in order to show the impact of those changes in the outcome of LR. In addition, BCLC staging was used to assess the limitations of this classification system and changes over the decade.
In our department, 500 liver resections (LR) were performed for hepatocellular carcinoma (HCC) over the 20 years between January 2000 and February 2020. The 208 cases performed through 2009 were designated as Era 1, and the 292 cases between 2010 and February 2020 were termed Era 2. We analyzed changes in the characteristics of HCC and mode of LR (Study 1), and final outcomes of LR are shown according to the BCLC staging classifications and eras using data from the 5 years after LR (Study 2).
In Era 1, the mean age of the patients was 68, while in Era 2 the mean age was 71, which was significantly older than the patients in Era 1. HCC that developed from non-B, non-C liver cirrhosis was significantly increased in Era 2 (45%) as compared to that in Era 1 (34%). Laboratory data were all comparable between the eras in patients undergoing LR for HCC. The size and numbers of the HCC as well as tumor markers were similar between the eras. As to the mode of LR, although the extent of LR was similar between the eras, the laparoscopic method was significantly increased in Era 2. Blood loss was significantly lower in Era 2 (mean 519 g) than in Era 1 (1,085 g). Patient survival and recurrence-free survival (RFS) were similar between the two eras, while RFS at 5 years after LR was better in Era 2. Even in the BCLC A category, only patients with a single HCC less than 5 cm showed best results, while patients with HCC within the rest of BCLC A and BCLC B showed a dismal outcome. There was no difference in OS and RFS between the eras after stratification by BCLC.
There are conspicuous changes in the baseline characteristics and mode of LR over 20 years, which should be taken into account for patient care and informed consent for patients undergoing LR going forward.
本研究旨在分析 20 年来 HCC 特征和 LR 模式的变化,以显示这些变化对 LR 结果的影响。此外,还使用 BCLC 分期评估该分类系统的局限性及其在这十年间的变化。
在我们科室,2000 年 1 月至 2020 年 2 月期间进行了 500 例肝癌(HCC)肝切除术(LR)。2009 年前进行的 208 例病例被指定为第 1 期(Era 1),2010 年至 2020 年 2 月期间进行的 292 例病例被称为第 2 期(Era 2)。我们分析了 HCC 特征和 LR 模式的变化(研究 1),并根据 BCLC 分期分类和 5 年后的 LR 数据(研究 2)显示了 LR 的最终结果。
在 Era 1 中,患者的平均年龄为 68 岁,而在 Era 2 中为 71 岁,明显高于 Era 1 中的患者。与 Era 1 相比,由非乙型肝炎和非丙型肝炎引起的非 B、非 C 肝硬化引起的 HCC 在 Era 2 中显著增加(45%)。LR 治疗 HCC 的患者的实验室数据在两个时期均无差异。两个时期的 HCC 大小和数量以及肿瘤标志物均相似。至于 LR 模式,尽管两个时期的 LR 程度相似,但在 Era 2 中,腹腔镜方法显著增加。Era 2 中的失血量(平均 519g)明显低于 Era 1(1085g)。两个时期的患者生存率和无复发生存率(RFS)相似,但 Era 2 在 LR 后 5 年的 RFS 更好。即使在 BCLC A 类别中,只有单个 HCC 小于 5cm 的患者表现出最佳结果,而 BCLC A 和 BCLC B 中的其余 HCC 患者的结果则很差。BCLC 分层后,两个时期的 OS 和 RFS 没有差异。
20 年来,基线特征和 LR 模式发生了明显变化,这应考虑到未来接受 LR 治疗的患者的护理和知情同意。